By proceeding, you agree to our Terms of Use and Privacy Policy.
Join us for the inaugural Gene Therapy Potency Assay Summit on August 29-31, where we will equip you with the necessary tools to identify, characterize, and measure potency in your gene therapy development. Our summit is dedicated to addressing the critical role of potency in ensuring the safety, efficacy, and consistency of your gene therapy product from pre-clinical development to commercialization.As the only industry-led event focused on potency challenges specific to gene therapy drug developers, we bring together over 60 analytical, bioassay, quality control, regulatory, and CMC experts. Our comprehensive program combines both strategic and technical content, providing actionable insights that you can take back to your team. Don't miss this opportunity to learn from the best and advance your gene therapy development.
Identify, and measure potency to ensure the safety & consistency of your gene therapy.
Enhance your expertise in advanced cell & gene therapy, developing potency assays, potency matrices, material restraints, and cell-based potency assays.
Get ready to tackle the greatest potency challenges in the industry, combining technical, data-heavy content with discussions and interactive sessions.
Elevate your expertise through the insights of industry stalwarts & understand biological variability between cell-based assays and how to overcome them.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tiss
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.